Enhancing the treatment landscape: PET-guided BrECADD for advanced-stage, classical Hodgkin lymphoma. Evens AM. Lancet 2024;404:312-313.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Evens AM. Enhancing the treatment landscape: PET-guided BrECADD for advanced-stage, classical Hodgkin lymphoma. Lancet 2024;404:312-313.
PMID: 39067891